Microvision Q2 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate, Sales $1.900M Beat $1.100M Estimate
Portfolio Pulse from Benzinga Newsdesk
Microvision (NASDAQ:MVIS) reported Q2 2024 GAAP EPS of $(0.11), beating the $(0.12) estimate. Sales were $1.900M, surpassing the $1.100M estimate and showing a 477.51% increase from the same period last year.
August 07, 2024 | 9:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Microvision reported better-than-expected Q2 2024 results with GAAP EPS of $(0.11) beating the $(0.12) estimate and sales of $1.900M surpassing the $1.100M estimate. This represents a significant 477.51% increase in sales compared to the same period last year.
The better-than-expected earnings and significant year-over-year sales growth are likely to positively impact Microvision's stock price in the short term. Beating both EPS and sales estimates indicates strong performance and could boost investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100